본문바로가기

News

Dr. Jae Sung Lee, CEO of Brightonix Imaging delivers a Plenary Talk at IEEE NSS/MIC/RTSD

Post by
Admin
Date
2023-11-20

Dr. Jae Sung Lee, CEO of Brightonix Imaging delivers a Plenary Talk at IEEE NSS/MIC/RTSD

Advancements in digital PET and artificial intelligence and promising technologies for the future





Brightonix Imaging, a medical imaging company, announced that Dr. Jae Sung Lee, CEO of Brightonix Imaging and Professor of Nuclear Medicine at Seoul National University, delivered a plenary talk at the Institute of Electrical and Electronics Engineers' Nuclear Science, Medical Imaging, and Room Temperature Semiconductor Detector Conference (IEEE NSS/MIC/RTSD) in Vancouver, Canada last week.

 

At the plenary session held on the 6th of this month, Lee delivered a lecture on the development history and recent trends of digital positron emission tomography (PET) and artificial intelligence technologies that have revolutionised the field of nuclear medicine molecular imaging, highlighting the significant impact of technological innovation on the development of medical imaging and introducing promising technologies for the future.


After receiving the Medical Imaging Technical Achievement Award from the IEEE's Nuclear and Plasma Society (NPSS) last year, which recognises a researcher who has made innovative contributions to the field of medical imaging technology based on their cumulative research achievements and leadership, Lee was invited to deliver the keynote lecture at this year's conference, the largest conference organised by the NPSS.

 

Lee was also invited to speak at the 'Ultra-Low Dose PET Workshop' on the 11th, the last day of the conference, where he introduced the latest artificial intelligence technology for ultra-low dose PET and the core technology of the Pharos system, a high-resolution, multi-purpose PET developed with the support of the Korea Medical Device Development Fund, and is planning a clinical evaluation at Seoul National University Hospital.




<Copyright ⓒ 약품신문 무단전재 및 재배포 금지>



TOP